Works matching IS 20953941 AND DT 2022 AND VI 19 AND IP 12
Results: 5
MiR-378a-3p acts as a tumor suppressor in gastric cancer via directly targeting RAB31 and inhibiting the Hedgehog pathway proteins GLI1/2.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 12, p. 1662, doi. 10.20892/j.issn.2095-3941.2022.0337
- By:
- Publication type:
- Article
Potential new applications of immunotherapy for neuroendocrine neoplasms: immune landscape, current status and future perspectives.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 12, p. 1649, doi. 10.20892/j.issn.2095-3941.2022.0489
- By:
- Publication type:
- Article
Heterogeneity of neutrophils in cancer: one size does not fit all.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 12, p. 1629, doi. 10.20892/j.issn.2095-3941.2022.0426
- By:
- Publication type:
- Article
Early detection of gastric cancer in China: progress and opportunities.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 12, p. 1622, doi. 10.20892/j.issn.2095-3941.2022.0655
- By:
- Publication type:
- Article
Inconsistent radiotherapy effects between primary tumors and axillary lymph nodes.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 12, p. 1617, doi. 10.20892/j.issn.2095-3941.2022.0590
- By:
- Publication type:
- Article